Samuel Klempner

70PUBLICATIONS
474CO-AUTHORS
Tumour immunologyPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (70)

|Aug 07, 2026
Spatial organisation of tumor-infiltrating B-cells informs immune checkpoint inhibitor response in Claudin 18.2-expressing gastric cancer.

|Jul 28, 2026
Rare Gastroesophageal Tumor Subtypes: Clinicopathologic Characteristics, Molecular Alterations, and Therapeutic Implications.

|Mar 23, 2026
The Pan-Tumor Landscape of Gene Amplifications and Copy Number Amplification Ratio for Established and Emerging Clinical Targets.

Jessica K Lee, Julia C F Quintanilha, Kuei-Ting Chen

|Mar 17, 2026
First-line zolbetuximab plus mFOLFOX6 and nivolumab in unresectable CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial.

Kohei Shitara, Hirokazu Shoji, Nicola Fazio

|Mar 11, 2026
Advances in the management of metastatic gastric cancer: current strategies and emerging therapeutics.

Joan Choo, Amalya Sargsyan, Vahe Khachatryan

|Mar 02, 2026
Claudin proteins as emerging therapeutic targets for solid tumours.

Antonio Saviano, Alberto Toso, Samuel J Klempner

Pageof 12

Frequent Collaborators

8 joint publications

Taehyang Lee

7 joint publications

Matthew Strickland

7 joint publications

Seung Tae Kim

6 joint publications

Kohei Shitara